GO
Loading...
 

Bull Case for Drug Stocks

Wed 04 Jan 12 | 12:20 PM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Bull Case for Drug Stocks

Wed 04 Jan 12 | 12:20 PM ET
Barbara Ryan, analyst at Deutsche Bank, explains why she has a "buy" rating on Bristol Myers Squibb, Pfizer and Merk with a $43 price target. "Bristol Myers is clearly the growth name in the group," she adds.
 
RELATED ARTICLES AND CONTENT
More Videos
  • No Articles Available
Latest Videos
Google's cost-per-click a concern: Pro
Wed 16 Apr 14 | 05:00 PM ET
Latest Videos
Yellen's dovish remarks help markets close at session highs
Wed 16 Apr 14 | 05:00 PM ET
Latest Videos
Honeybee Capital CEO: HFT form of cancer
Wed 16 Apr 14 | 04:45 PM ET
Latest Videos
Virtual wild west
Wed 16 Apr 14 | 04:38 PM ET
Go
Displaying results for: Latest Video | US